J Rheum Dis.  2021 Oct;28(4):173-175. 10.4078/jrd.2021.28.4.173.

Delineating the Risk of Lupus Nephritis: How Far Have We Come?

• Lee J

• KMID: 2520429
• DOI: http://doi.org/10.4078/jrd.2021.28.4.173

Reference

1. Tsokos GC. 2011; Systemic lupus erythematosus. N Engl J Med. 365:2110–21. DOI: 10.1056/NEJMra1100359. PMID: 22129255.

2. Hanly JG, O'Keeffe AG, Su L, Urowitz MB, Romero-Diaz J, Gordon C, et al. 2016; The frequency and outcome of lupus nephritis: results from an international inception cohort study. Rheumatology (Oxford). 55:252–62. DOI: 10.1093/rheumatology/kev311. PMID: 26342222. PMCID: PMC4939728.

3. Zhang L, Lee G, Liu X, Pascoe EM, Badve SV, Boudville NC, et al. 2016; Long-term outcomes of end-stage kidney disease for patients with lupus nephritis. Kidney Int. 89:1337–45. DOI: 10.1016/j.kint.2016.02.014. PMID: 27165824.

4. Vandepapelière J, Aydin S, Cosyns JP, Depresseux G, Jadoul M, Houssiau FA. 2014; Prognosis of proliferative lupus nephritis subsets in the Louvain Lupus Nephritis inception Cohort. Lupus. 23:159–65. DOI: 10.1177/0961203313514623. PMID: 24300780.

5. Lisnevskaia L, Murphy G, Isenberg D. 2014; Systemic lupus erythematosus. Lancet. 384:1878–88. DOI: 10.1016/S0140-6736(14)60128-8. PMID: 31180031.

6. Wahren-Herlenius M, Dörner T. 2013; Immunopathogenic mechanisms of systemic autoimmune disease. Lancet. 382:819–31. DOI: 10.1016/S0140-6736(13)60954-X. PMID: 23993191.

7. Ntatsaki E, Isenberg D. 2015; Risk factors for renal disease in systemic lupus erythematosus and their clinical implications. Expert Rev Clin Immunol. 11:837–48. DOI: 10.1586/1744666X.2015.1045418. PMID: 25973642.

8. Shin JM, Kim D, Kwon YC, Ahn GY, Lee J, Park Y, et al. 2021; Clinical and genetic risk factors associated with the presence of lupus nephritis. J Rheum Dis. 28:150–8. DOI: 10.4078/jrd.2021.28.3.150.

9. Ho CT, Mok CC, Lau CS, Wong RW. 1998; Late onset systemic lupus erythematosus in southern Chinese. Ann Rheum Dis. 57:437–40. DOI: 10.1136/ard.57.7.437. PMID: 9797573. PMCID: PMC1752656.

10. Formiga F, Moga I, Pac M, Mitjavila F, Rivera A, Pujol R. 1999; Mild presentation of systemic lupus erythematosus in elderly patients assessed by SLEDAI. SLE Disease Activity Index. Lupus. 8:462–5. DOI: 10.1177/096120339900800609. PMID: 10483015.

11. Seligman VA, Lum RF, Olson JL, Li H, Criswell LA. 2002; Demographic differences in the development of lupus nephritis: a retrospective analysis. Am J Med. 112:726–9. DOI: 10.1016/S0002-9343(02)01118-X. PMID: 12079714.

12. Alba P, Bento L, Cuadrado MJ, Karim Y, Tungekar MF, Abbs I, et al. 2003; Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis. Ann Rheum Dis. 62:556–60. DOI: 10.1136/ard.62.6.556. PMID: 12759294. PMCID: PMC1754557.

13. Reppe Moe SE, Molberg Ø, Strøm EH, Lerang K. 2019; Assessing the relative impact of lupus nephritis on mortality in a population-based systemic lupus erythematosus cohort. Lupus. 28:818–25. DOI: 10.1177/0961203319847275. PMID: 31072277.

14. Tanha N, Hansen RB, Nielsen CT, Faurschou M, Jacobsen S. 2018; Clinical and serological associations with the development of incident proteinuria in Danish patients with systemic lupus erythematosus. J Rheumatol. 45:934–41. DOI: 10.3899/jrheum.170933. PMID: 29657143.

15. Bastian HM, Roseman JM, McGwin G Jr, Alarcón GS, Friedman AW, Fessler BJ, et al. 2002; Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis. Lupus. 11:152–60. DOI: 10.1191/0961203302lu158oa. PMID: 12004788.

16. Duarte-García A, Barr E, Magder LS, Petri M. 2017; Predictors of incident proteinuria among patients with SLE. Lupus Sci Med. 4:e000200. DOI: 10.1136/lupus-2016-000200. PMID: 29177060. PMCID: PMC5691294.

17. Barr RG, Seliger S, Appel GB, Zuniga R, D'Agati V, Salmon J, et al. 2003; Prognosis in proliferative lupus nephritis: the role of socio-economic status and race/ethnicity. Nephrol Dial Transplant. 18:2039–46. DOI: 10.1093/ndt/gfg345. PMID: 13679478.

18. Petri M, Perez-Gutthann S, Longenecker JC, Hochberg M. 1991; Morbidity of systemic lupus erythematosus: role of race and socioeconomic status. Am J Med. 91:345–53. DOI: 10.1016/0002-9343(91)90151-M. PMID: 1951378.

19. Bell DA. 1988; SLE in the elderly--is it really SLE or systemic Sjögren's syndrome? J Rheumatol. 15:723–4. PMID: 3172090.

20. Catoggio LJ, Skinner RP, Smith G, Maddison PJ. 1984; Systemic lupus erythematosus in the elderly: clinical and serological characteristics. J Rheumatol. 11:175–81. PMID: 6610051.

21. Salmon JE, Millard S, Schachter LA, Arnett FC, Ginzler EM, Gourley MF, et al. 1996; Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans. J Clin Invest. 97:1348–54. DOI: 10.1172/JCI118552. PMID: 8636449. PMCID: PMC507190.

22. Karassa FB, Trikalinos TA, Ioannidis JP. FcgammaRIIa-SLE Meta-Analysis Investigators. 2002; Role of the Fcgamma receptor IIa polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis. Arthritis Rheum. 46:1563–71. DOI: 10.1002/art.10306. PMID: 12115187.

23. Chung SA, Brown EE, Williams AH, Ramos PS, Berthier CC, Bhangale T, et al. 2014; Lupus nephritis susceptibility loci in women with systemic lupus erythematosus. J Am Soc Nephrol. 25:2859–70. DOI: 10.1681/ASN.2013050446. PMID: 24925725. PMCID: PMC4243339.

24. Lanata CM, Nititham J, Taylor KE, Chung SA, Torgerson DG, Seldin MF, et al. 2018; Genetic contributions to lupus nephritis in a multi-ethnic cohort of systemic lupus erythematous patients. PLoS One. 13:e0199003. DOI: 10.1371/journal.pone.0199003. PMID: 29953444. PMCID: PMC6023154.

25. Igo RP Jr, Kinzy TG, Cooke Bailey JN. 2019; Genetic risk scores. Curr Protoc Hum Genet. 104:e95. DOI: 10.1002/cphg.95. PMID: 31765077. PMCID: PMC6941594.

26. Krarup NT, Borglykke A, Allin KH, Sandholt CH, Justesen JM, Andersson EA, et al. 2015; A genetic risk score of 45 coronary artery disease risk variants associates with increased risk of myocardial infarction in 6041 Danish individuals. Atherosclerosis. 240:305–10. DOI: 10.1016/j.atherosclerosis.2015.03.022. PMID: 25864160.

27. Helfand BT. 2016; A comparison of genetic risk score with family history for estimating prostate cancer risk. Asian J Androl. 18:515–9. DOI: 10.4103/1008-682X.177122. PMID: 27004541. PMCID: PMC4955172.

28. Reid S, Alexsson A, Frodlund M, Morris D, Sandling JK, Bolin K, et al. 2020; High genetic risk score is associated with early disease onset, damage accrual and decreased survival in systemic lupus erythematosus. Ann Rheum Dis. 79:363–9. DOI: 10.1136/annrheumdis-2019-216227. PMID: 31826855. PMCID: PMC7034364.

29. MacKinnon DP, Fairchild AJ, Fritz MS. 2007; Mediation analysis. Annu Rev Psychol. 58:593–614. DOI: 10.1146/annurev.psych.58.110405.085542. PMID: 16968208. PMCID: PMC2819368.